Staeger R, Tastanova A, Ghosh A, Winkelbeiner N, et al. Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T-cells in uveal melanoma patients. J Clin Invest 2025 Apr 29:e181464. doi: 10.1172/JCI181464.
PMID: 40311102